Elevance Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Elevance Health, Inc. (ELV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ELV insiders buying or selling?
In the last 12 months, Elevance Health, Inc. insiders reported 3 open-market purchases ($2.2M) and 5 sales ($1.7M) — net buying of $493.1K. Since January 2018, Trabud has recorded 98 Form 4 filings for ELV: 8 buys ($8.1M) and 90 sells ($251.9M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $1.0M by Gail Boudreaux (President and CEO) on Jul 17, 2026. SEC ↗
- The most recent open-market purchase was reported on Jul 17, 2026 (3 months ago).
Key Statistics (January 2018 – Jul 17, 2026)
Total Form 4 filings
98
SEC EDGAR
Insider filers
20
Insider buys (8)
$8.1M
Insider sells (90)
$251.9M
Insider sentiment
Net sellingNet insider flow of $243.8M in net selling since January 2018, and $493.1K in net buying over the last 12 months.
Recent ELV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Ramiro G Peru | Director | Purchase | 1.0K | $366.05 | $366.1K | SEC ↗ |
| Jul 17, 2026 | Gail Boudreaux | President and CEO | Purchase | 2.7K | $367.79 | $1.0M | SEC ↗ |
| Jun 15, 2026 | Ronald W Penczek | CAO & Controller | Sale | 369 | $403.16 | $148.8K | SEC ↗ |
| Jun 12, 2026 | Robert L Dixon JR | Director | Sale | 151 | $401.77 | $60.7K | SEC ↗ |
| May 20, 2026 | Ronald W Penczek | CAO & Controller | Sale | 1.5K | $403.13 | $617.2K | SEC ↗ |
| Mar 23, 2026 | Amy W Schulman | Director | Sale | 26 | $287.50 | $7.5K | SEC ↗ |
| Mar 9, 2026 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 3.2K | $284.92 | $910.6K | SEC ↗ |
| Mar 6, 2026 | Steven H Collis | Director | Purchase | 3.0K | $289.84 | $869.5K | SEC ↗ |
| Aug 21, 2025 | Susan D. Devore | Director | Purchase | 1.2K | $312.15 | $374.6K | SEC ↗ |
| Jul 18, 2025 | Gail Boudreaux | President and CEO | Purchase | 8.5K | $286.94 | $2.4M | SEC ↗ |
| Apr 25, 2025 | Mark Kaye | EVP & CFO | Sale | 4.6K | $424.82 | $1.9M | SEC ↗ |
| Mar 11, 2025 | Ronald W Penczek | CAO & Controller | Sale | 443 | $415.13 | $183.9K | SEC ↗ |
| Mar 5, 2025 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 3.5K | $396.30 | $1.4M | SEC ↗ |
| Oct 18, 2024 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 7.4K | $432.14 | $3.2M | SEC ↗ |
| Aug 6, 2024 | Ramiro G Peru | Director | Sale | 753 | $531.52 | $400.2K | SEC ↗ |
| Jul 23, 2024 | Gail Boudreaux | President and CEO | Sale | 34.0K | $500.98 | $17.0M | SEC ↗ |
| Jul 22, 2024 | Robert L Dixon JR | Director | Sale | 305 | $506.76 | $154.6K | SEC ↗ |
| Apr 25, 2024 | Felicia F Norwood | EVP & President,Gov Health Ben | Sale | 20.3K | $533.34 | $10.8M | SEC ↗ |
| Mar 12, 2024 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 2.4K | $500.46 | $1.2M | SEC ↗ |
| Mar 8, 2024 | Ronald W Penczek | CAO & Controller | Sale | 916 | $504.58 | $462.2K | SEC ↗ |
| Mar 5, 2024 | Peter D Haytaian | EVP & Pres Carelon & CarelonRx | Sale | 21.1K | $500.18 | $10.6M | SEC ↗ |
| Feb 9, 2024 | Ramiro G Peru | Director | Sale | 753 | $500.00 | $376.5K | SEC ↗ |
| Dec 15, 2023 | Blair Williams Todt | EVP, CLO & CAO | Sale | 5.5K | $484.02 | $2.7M | SEC ↗ |
| Dec 1, 2023 | Ronald W Penczek | CAO & Controller | Sale | 1.1K | $475.17 | $501.3K | SEC ↗ |
| Oct 26, 2023 | Ronald W Penczek | CAO & Controller | Sale | 64 | $454.35 | $29.1K | SEC ↗ |
Showing the 25 most recent of 98 Form 4 filings for Elevance Health, Inc..
Most active ELV insiders
- Peter D Haytaian19 filings
- Ronald W Penczek17 filings
- Ramiro G Peru8 filings
- Robert L Dixon JR8 filings
- Gloria M Mccarthy7 filings
Ask anything about ELV insider activity
Use Trabud's AI agent to query Elevance Health, Inc.'s Form 4 history in plain English — "Show me ELV CEO purchases this year" or compare it against any other ticker.
Open the AI agentELV insider trading FAQ
Are Elevance Health, Inc. insiders buying or selling?
In the last 12 months, Elevance Health, Inc. insiders reported 3 open-market purchases ($2.2M) and 5 sales ($1.7M) — net buying of $493.1K. Since January 2018, Trabud has recorded 98 Form 4 filings for ELV: 8 buys ($8.1M) and 90 sells ($251.9M). Over the full record that is net selling of $243.8M.
How many insiders trade ELV stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Elevance Health, Inc.. The most recent filing was accepted on Jul 17, 2026.
Where does Trabud get ELV insider trading data?
All ELV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.